N-(2-(7-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl)acetamide;Acetamide, N-[2-(1,2,3,4-tetrahydro-7-methoxy-1-naphthalenyl)ethyl]-
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Agomelatine Impurity refers to chemical variants generated during the <strong>synthesis</strong> of agomelatine, primarily used as reference standards. The core structure involves N-[(4-cyclopropylmethylpiperazin-1-yl)methyl]-2-(naphthalen-2-yloxy)acetamide derivatives. Specific impurities vary by generation process, often characterized by distinct molecular formulas and CAS numbers not universally standardized.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Used in HPLC method development to identify and quantify trace degradants.</li>
<li><strong>R&D:</strong> Serves as a comparator for establishing stability-indicating assays in pharmaceutical manufacturing.</li>
<li><strong>Regulatory Compliance:</strong> Essential for documenting impurity profiles in Drug Master Files (DMF).</li>
</ul>
<h3>Precautions</h3>
<p>Store at controlled room temperature away from light and moisture. Handle with appropriate PPE due to potential sensitization risks. Do not use in clinical trials without validated purity certificates.</p>